ArticleFuture oncology (London, England)2025

ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine.

Eleni Vrana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.